After hours closed out at $144.00
SKX is now $142.11 per share!
Did they schedule a date for earnings?
What's David Einhorn's number one position? That's the one I want!
Gilead bought the voucher from Knight Pharmaceutical, a Canadian company, in November 2014, for $125 million. Gilead has one year from that date to execute said voucher for priority review.